EGFR Inhibitors and Radiation in HNSCC
Journal:
Current Cancer Therapy Reviews
Volume:
3
Page:
255-266
Author(s):
Laura QM Chow, Changhu Chen and David Raben
Optimizing Anti-EGFR Strategies in Cancer Treatment
Journal:
Current Cancer Therapy Reviews
Volume:
3
Page:
267-275
Author(s):
Luca Toschi, Giovanna Finocchiaro, Isabella Garassino, Fabio De Vincenzo, Elisabetta Campagnoli, Giovanni Luca Ceresoli, Raffaele Cavina, Paolo Andrea Zucali, Armando Santoro and Federico Cappuzzo
Mechanisms of Intrinsic and Acquired Resistance to EGFR Inhibitors
Journal:
Current Cancer Therapy Reviews
Volume:
3
Page:
276-283
Author(s):
Floriana Morgillo, Giampaolo Tortora and Fortunato Ciardiello
Methodological Issues of Clinical Research with EGFR Inhibitors
Journal:
Current Cancer Therapy Reviews
Volume:
3
Page:
292-302
Author(s):
Alessandro Morabito, Maria Carmela Piccirillo, Katia Monaco, Fabiano Falasconi, Nicola Normanno and Francesco Perrone
Molecular Targets of FoxP3+ Regulatory T Cells
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
7
Page:
1136-1143
Author(s):
Chang H. Kim
Onconeural Versus Paraneoplastic Antigens?
Journal:
Current Medicinal Chemistry
Volume:
14
Page:
2489-2494
Author(s):
S. B. Eichmuller and A. V. Bazhin
Antimicrobial Peptides in Oral Cancer
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3119-3130
Author(s):
Jens E. Meyer and Jurgen Harder
Epigenetics: Relations to Disease and Laboratory Findings
Journal:
Current Medicinal Chemistry
Volume:
14
Page:
2642-2653
Author(s):
Masato Maekawa and Yoshihisa Watanabe
Connexins as Precocious Markers and Molecular Targets for Chemical and Pharmacological Agents in Carcinogenesis
Journal:
Current Medicinal Chemistry
Volume:
14
Page:
2288-2303
Author(s):
G. Pointis, C. Fiorini, J. Gilleron, D. Carette and D. Segretain
Targeting Microtubules to Inhibit Angiogenesis and Disrupt Tumour Vasculature:Implications for Cancer Treatment
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
566-581
Author(s):
Eddy Pasquier, Nicolas Andre and Diane Braguer